Characterization of physiologically regulated vectors for the treatment of ischemic disease

Human Gene Therapy

Volumn 10, Issue 13, 1999, Pages 2197-2208

  Boast, Kate ^a   Binley, Katie ^b   Iqball, Sharifah ^b   Price, Toby ^b   Spearman, Hayley ^b   Kingsman, Susan ^a,b   Kingsman, Alan ^a,b   Naylor, Stuart ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OXYGEN; TRANSCRIPTION FACTOR; VIRUS VECTOR;

ARTICLE; BLOOD VESSEL OCCLUSION; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; HEART MUSCLE; HUMAN; HUMAN CELL; HYPOXIA; IMMEDIATE EARLY GENE; ISCHEMIA; OXYGEN CONCENTRATION; PROTEIN BINDING; PROTEIN STABILITY; RETROVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANOXIA; CELL LINE; DNA, RECOMBINANT; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REGULATOR; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RETROVIRIDAE;

EID: 0033198913     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017185     Document Type: Article

References (56)

1. ACKER, H. (1994). Mechanisms and meaning of cellular oxygen sensing in the organism. Respir. Physiol. 95, 1-10.
2. BABA, T., UCHIMURA, I., FUJISAWA, K., MOROHOSHI, M., ASAOKA, H., TANAKA, A., and NUMANO, F. (1997). Production of interleukin-6 induced by hypoxia linked to peripheral arterial disease. Ann. N.Y. Acad. Sci. 811, 542-548.
3. BELSHAM, G.J., and BRANGWYN, J.K. (1992). Dual initiation sites of protein synthesis on foot-and-mouth disease virus RNA are selected following internal entry and scanning of ribosomes in vivo. EMBO J. 11, 1105-1110.
4. BLANCHARD, K.L., ACQUIAVIVA, A.M., GALSON, D.L., and BUNN, H.F. (1992). Hypoxic induction of the human erythropoietin gene: Cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol. Cell. Biol. 12, 5373-5385.
5. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HASLER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
6. BUNN, H.F., and POYTON, R.O. (1996). Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 78, 839-885.
7. CHERINGTON, V., CHIANG, G.G., McGRATH, C.A., GAFFNEY, A., GALANOPOULOS, T., MERRILL, W., BIZINKAUSKAS, C.B., HANSEN, M., SOBOLEWSKI, J., LEVINE, P.H., GREEN-BERGER, J.S., and HURWITZ, D.R. (1998). Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Hum. Gene Ther. 9, 1397-1407.
8. CLAFFEY, K.P., SHIH, S.C., MULLEN, A., DZIENNIS, S., CUSICK, J.L., ABRAMS, K.R., LEE, S.W., and DETMAR, M. (1998). Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell. 9, 469-181.
9. CONNORS, T.A. (1995). The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2, 702-709.
10. CREWS, S.T. (1998). Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 12, 607-620.
11. DACHS, G.U., PATTERSON, A.V., FIRTH, J.D., RATCLIFFE, P.J., TOWNSEND, K.M., STRATFORD, I.J., and HARRIS, A.L. (1997). Targeting gene expression to hypoxic tumor cells. Nature Med. 3, 515-520.
12. DITZEL, J. (1980). Affinity hypoxia as a pathogenetic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol. Suppl. (Copenh). 238, 39-55.
13. DUNN, T. (1997). Oxygen and cancer. N. C. Med. J. 58, 140-143.
14. EBERT, B.L., and BUNN, H.F. (1998). Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell. Biol. 18, 4089-4096.
15. EMA, M., SHINICHIRO, T., YOKOTANI, N., SOGAWA, K., MATSUDA, Y., and FUJII-KURIYAMA, Y. (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U.S.A. 94, 4273-1278.
16. FIRTH, J.D., EBERT, B.L., PUGH, C.W., and RATCLIFFE, P.J. (1994). Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. U.S.A. 91, 6496-6500.
17. FLAMME, I., FROHLICH, T., VON REUTERN, M., KAPPEL, A., ANNETTE, D., and RISAU, W. (1997). HRF, a putative basic helix-loop-helix-PAS-domain transcription factor, is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels. Mech. Dev. 63, 51-60.
18. HARRIS, J.D., GUTIERREZ, A.A., HURST, H.C., SIKORA, K., and LEMOINE, N.R. (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1, 170-175.
19. HERSHKO, C., KONIJN, A.M., and LINK, G. (1998). Iron chelators for thalassaemia. Br. J. Haematol. 101, 399-406.
20. IIDA, A., CHEN, S.T., FRIEDMANN, T., and YEE, J.K. (1996). Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J. Virol. 70, 6054-6059.
21. 2 tension. Am. J. Phyisiol. 271, C1172-C1180.
22. JONES, K.A., KADONAGA, J.T., LUCIW, P.A., and TJIAN, R. (1986). Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232, 755-759.
23. KIM, S.H., YU, S.S., PARK, J.S., ROBBINS, P.D., AN, C.S., and KIM, S. (1998). Construction of retroviral vectors with improved safety, gene expression, and versatility. J. Virol. 72, 994-1004.
24. LANDAU, N.R., PAGE, K.A., and LITTMAN, D.R. (1991). Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65, 162-169.
25. LEE, C.H., LIU, M., SIE, K.L., and LEE, M.S. (1996). Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer. Anticancer Res. 16, 1805-1811.
26. LEVY, N.S., CHUNG, S., FURNEAUX, H., and LEVY, A.P. (1998). Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417-6423.
27. MAPP, P.I., GROOTVELD, M.C., and BLAKE, D.R. (1995). Hypoxia, oxidative stress and rheumatoid arthritis. Br. Med. Bull. 51, 419-436.
28. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-982, 984-986, 989-990.
29. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242. [Published erratum appears in Mol. Cell. Biol. 1992;12:433].
30. MILLER, N., and WHELAN, J. (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8, 803-815.
31. PRENTICE, H., BISHOPRIC, N.H., HICKS, M.N., DISCHER, D.J., WU, X., WYLIE, A.A., and WEBSTER, K.A. (1997). Regulated expression of a foreign gene targeted to the ischaemic myocardium. Cardiovasc. Res. 35, 567-574.
32. RAM, Z., CULVER, K.W., OSHIRO, E.M., VIOLA, J.J., DEVROOM, H.L., OTTO, E., LONG, Z., CHIANG, Y., McGARRITY, G.J., MUUL, L.M., KATZ, D., BLAESE, R.M., and OLDFIELD, E.H. (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med. 3, 1354-1361. [See comments].
33. RING, C.J., BLOUIN, P., MARTIN, L.A., HURST, H.C., and LEMOINE, N.R. (1997). Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme. Gene Ther. 4, 1045-1052.
34. RINSCH, C., REGULIER, E., DEGLON, N., DALLEY, B., BEUZARD, P., and AEBISCHER, P. (1997). A gene therapy approach to regulated delivery of eruthropoietin as a function of oxygen tension. Hum. Gene Ther. 8, 1881-1889. [See comments]
35. RONDON, I.J., MACMILLAN, L.A., BECKMAN, B.S., GOLDBERG, M.A., SCHNEIDER, T., BUNN, H.F., and MALTER, J.S. (1991). Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J. Biol. Chem. 266, 16594-16598.
36. RUSSELL, S.J., HAWKINS, R.E., and WINTER, G. (1993). Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21, 1081-1085.
37. SAEZ, E., NO, D., WEST, A., and EVANS, R.M. (1997). Inducible gene expression in mammalian cells and transgenic mice. Curr. Opin. Biotechnol. 8, 608-616.
38. SAFI, J., JR., GLOE, T.R., RICCIONI, T., KOVESDI, I., and CAPOGROSSI, M.C. (1997). Gene therapy with angiogenic factors: A new potential approach to the treatment of ischemic diseases. J. Mol. Cell. Cardiol. 29, 2311-2325.
39. SEMENZA, G.L., NEJFELT, M.K., CHI, S.M., and ANTONARAKIS, S.E. (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. U.S.A. 88, 5680-5684.
40. SEMENZA, G.L., ROTH, P.H., FANG, H.M., and WANG, G.L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763.
41. SEMENZA, G.L., JIANG, B.H., LEUNG, S.W., PASSANTINO, R., CONCORDET, J.P., MAIRE, P., and GIALLONGO, A. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529-32537.
42. SEMENZA, G.L., AGANI, F., IYER, N., JIANG, B., LEUNG, S., WIENER, C., and YU, A. (1998). Hypoxia-inducible factor 1: From molecular biology to cardiopulmonary physiology. Chest 114, 40S-45S.
43. SCHOCKETT, P.E., and SCHATZ, D.G. (1996). Diverse strategies for tetracycline-regulated inducible gene expression. Proc. Natl. Acad. Sci. U.S.A. 93, 5173-5176. [See comments].
44. SINGBARTL, G. (1994). Adverse events of erythropoietin in long-term and in acute/short-term treatment. Clin. Invest. 72, S36-S43.
45. SLAVIKOVA, K., and MASSOURIDOU, E. (1995). DNA-mediated gene transfer into mammalian cells and cancer. Neoplasma 42, 293-297.
46. SONEOKA, Y., CANNON, P.M., RAMSDALE, E.E., GRIFFITHS, J.C., ROMANO, G., KINGSMAN, S.M., KINGSMAN, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
47. SPENCER, D.M., WANDLESS, T.J., SCHREIBER, S.L., and CRABTREE, G.R. (1993). Controlling signal transduction with synthetic ligands. Science 262, 1019-1024. [See comments]
48. STEIN, I., ITIN, A., EINAT, P., SKALITER, R., GROSSMAN, Z., and KESHET, E. (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia. Mol. Cell. Biol. 18, 3112-3119.
49. TAKEUCHI, Y., SIMPSON, G., VILE, R.G., WEISS, R.A., and COLLINS, M.K. (1992). Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology 186, 792-794.
50. TIAN, H., McKNIGHT, S.L., and RUSSELL, D.W. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72-82.
51. VILE, R.G., and RUSSELL, S.J. (1995). Retroviruses as vectors. Br. Med. Bull. 51, 12-30.
52. WANG, G.L., and SEMENZA, G.L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
53. WENGER, R., and GASSMAN, M. (1997). Oxygen(es) and the hypoxia inducible factor 1. J. Biol. Chem. 378, 609-616.
54. WIESENER, M.S., TURLEY, H., ALLEN, W.E., WILLIAM, C., ECKARDT, K., TALKS, K.L., WOOD, S.M., GATTER, K.C., HARRIS, A.L., PUGH, C.W., RATCLIFFE, P.J., and MAXWELL, P.H. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92, 2260-2268.
55. YOUNG, J.A., BATES, P., WILLERT, K., and VARMUS, H.E. (1990). Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250, 1421-1423.
56. ZELZER, E., WAPPNER, P., and SHILO, B.Z. (1997). The PAS domain confers target gene specificity of Drosophila bHLH/PAS proteins. Genes Dev. 11, 2079-2089.